Cognis Signs CLA Agreement with Bringwell

16/03/06 Global nutritional ingredients and speciality chemicals company, Cognis, and Bringwell International AB, have agreed to sign an exclusive Trademark Sub-licence Agreement for Tonalin CLA, when sold as dietary supplements through health food stores in Norway and Sweden.

CLA is a polyunsaturated, conjugated fatty acid that is a natural part of the human diet found primarily in meat and dairy products.  Cognis produces Tonalin CLA through a new proprietary process that converts linoleic acid from safflowers into CLA, providing the highest quality of CLA available.  Tonalin CLA contains the lowest amount of non-naturally occurring isomers, a patent-protected attribute that provides food and dietary supplement manufacturers with the highest levels of ingredients known to be beneficial.  CLA is available in several product forms – oil and water-dispersible powder – that offer manufacturers a broad range of options for their new products. 

Bringwell International AB is a leading company with patented own-developed and in-licensed brands and ingredients. In Norway, Bringwell is represented by Medtech Pharma Norge, the leading company in health food supplements in that country.

Martin Weidner, Business Manager North Europe at Cognis Nutrition & Health calls Bringwell “the ideal licensing partner “, adding: “With it’s strong focus on health food supplements, Bringwell is ideally placed to realise the growth potential for Tonalin CLA in Scandinavia”.

“We are very excited about Tonalin CLA”, said Anders Struksnes, Business Strategy Manager at Bringwell International.  Recent recognition from the US National Institutes of Health (NIH), one of the world´s foremost scientific authorities, continues to distinguish Tonalin as the leading brand of CLA for optimal body composition. Such recognition clearly demonstrates the opportunities that lie ahead of us,” he said.